Adverum Biotechnologies (NASDAQ:ADVM) & Lexeo Therapeutics (NASDAQ:LXEO) Head-To-Head Analysis
Adverum Biotechnologies (NASDAQ:ADVM – Get Free Report) and Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Valuation & Earnings This table compares Adverum […]
More Stories
CVS Health (NYSE:CVS) Raised to Buy at TD Cowen
TD Cowen upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a buy rating in...
Barclays Trims Devon Energy (NYSE:DVN) Target Price to $46.00
Devon Energy (NYSE:DVN – Free Report) had its price objective decreased by Barclays from $55.00 to $46.00 in a report...
Digital Realty Trust (NYSE:DLR) Upgraded at HSBC
HSBC upgraded shares of Digital Realty Trust (NYSE:DLR – Free Report) from a reduce rating to a hold rating in...
Lloyds Banking Group (NYSE:LYG) Receives New Coverage from Analysts at The Goldman Sachs Group
The Goldman Sachs Group started coverage on shares of Lloyds Banking Group (NYSE:LYG – Free Report) in a research report...
argenx (NASDAQ:ARGX) Downgraded by Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft downgraded shares of argenx (NASDAQ:ARGX – Free Report) from a buy rating to a hold rating in...
Amazon.com (NASDAQ:AMZN) Receives Overweight Rating from Morgan Stanley
Morgan Stanley reissued their overweight rating on shares of Amazon.com (NASDAQ:AMZN) in a research report sent to investors on Thursday...